Breathonix is a spin-off company from the National University of Singapore (NUS) that develops easy breath tests for disease detection. Using its proprietary breath sampling device and data analysis algorithms, Breathonix has successfully demonstrated the detection of Covid-19, early-stage lung cancer, as well as misdiagnosed Tuberculosis. Breathonix’s technology can complete one breath test within 1 minute, the fastest among its competitors.
Our Vision is to become the global leader in non-invasive breath tests for disease detection.
diagnostics, breathalyser, medtech, ai, data analysis, covid19 screening, saas